Imaging of tumor physiology: Impacts on clinical radiation oncology

Experimental Oncology

Volumn 32, Issue 3, 2010, Pages 149-152

  Astner, S T ^a   Shi, K ^a   Vaupel, P ^a   Molls, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biological imaging; Dose painting; Hypoxia; Perfusion; Radiotherapy; Tumor physiology

Indexed keywords

NITROIMIDAZOLE;

CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; TREATMENT PLANNING; TUMOR MICROENVIRONMENT;

ANIMALS; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77957741484     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Sutherland RM. Cell and environment interactions in tumor microregions; the multicell spheroid model. Science 1988; 240: 177-84.
2. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-65. (Pubitemid 20008770)
3. Vaupel P. Physiological mechanisms of treatment resistance. In: Molls M, Vaupel P, Nieder C, et al., eds. The impact of tumor biology on cancer treatment and multidisciplinary strategies. Berlin, Heidelberg, Germany: Springer, 2009: 273-290.
4. Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000; 47: 551-60. (Pubitemid 30317470)
5. 18)F]-2-fluoro-2′-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia. Strahlenther Onkol 2004; 180: 616-22.
6. Grosu AL, Souvatzoglou M, Röper B, et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 69: 541-51. (Pubitemid 47380112)
7. Lehtiö K, Eskola O, Viljanen T. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004; 59: 971-82. (Pubitemid 38834289)
8. 18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006; 24: 2098-104.
9. 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 2005; 46: 253-60.
10. 18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 2009; 75: 101-8.
11. 18F]-Fmiso PET data to analyse tumour hypoxia. Phys Med Biol 2005; 50: 2209-24.
12. 2O in patients with head and neck tumors. J Nucl Med 2010; 51: 1-9.
13. 18F-FMISO in head and neck cancer. Int J Radiat Oncol Biol Phys 2008; 70: 235-42.
14. 18F-FMISO PET. Int J Radiat Oncol Biol Phys 2008; 70: 1219-28.
15. Tatum JL, Kelloff GJ, Gillies RJ, et al. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006; 82: 699-757.
16. Hoskin PJ, Carnell DM, Taylor NJ, et al. Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. Int J Radiat Oncol Biol Phys 2007; 68: 1065-71.
17. Chopra S, Foltz WD, Milosevic MF, et al. Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: a pilot study in men with prostate cancer. Int J Radiat Biol 2009; 85: 805-13.
18. Vaupel P, Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 2004; 9: 4-9. (Pubitemid 39658340)
19. Vaupel P. Hypoxia and aggressive tumor phenotype: Implications for therapy and prognosis. Oncologist 2008; 13: 21-6.
20. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 2004; 14: 198-206. (Pubitemid 38903223)
21. Molls M, Feldmann HJ, Sievers K. Clinical investigations on blood perfusion in human malignancies of the pelvis and abdomen: significance for tumor therapy. Experientia 1992; 61: 368-72.
22. Kiessling F, Farhan N, Lichy MP, et al. Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockade with DC101. Neoplasia 2004; 6: 213-23. (Pubitemid 38657077)
23. Hermans R, Meijerink M, van den Bogaert W, et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 1351-6. (Pubitemid 37443976)
24. Loncaster JA, Carrington BM, Sykes JR, et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002; 54: 759-67.
25. Weber MA, Thilmann C, Lichy MP, et al. Assessment of irradiated brain metastases by means of arterial spin-labelling and dynamic susceptibility weighted contrast-enhanced perfusion MRI: initial results. Invest Radiol 2004; 39: 277-87. (Pubitemid 38520662)
26. Lazanyi KS, Abramyuk A, Wolf G, et al. Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapy. Lung Cancer 2010; doi:10.1016/j.lungcan.2010. 03.004.
27. 2O. J Nucl Med 2004; 45: 1851-9.
28. Jansen JF, Schöder H, Lee NY, et al. Noninvasive assessment of tumor microenvironment using dynamic contrastenhanced magnetic resonance imaging and (18)F-Fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys 2010; 77: 1403-10.
29. Barthel H, Cleij MC, Collingridge DR, et al. 3′-deoxy-3′- [18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res 2003; 63: 3791-8. (Pubitemid 36793068)